Pharmaceutical Export to Indonesia from India

Indonesia has one of Southeast Asia's largest pharmaceutical markets, supported by a substantial healthcare sector, local pharmaceutical manufacturing and international trade. India is an established pharmaceutical supplier to Indonesia. In 2025, Indonesia imported approximately US$1.42 billion of pharmaceutical products, including approximately US$128.90 million from India.

Global Entra Pharma is an Indian pharmaceutical manufacturer offering selected finished pharmaceutical formulations for pharmaceutical companies, distributors and healthcare businesses in Indonesia.

Pharmaceutical Manufacturing for Indonesia

Global Entra Pharma specializes in selected pharmaceutical dosage forms, including:

• Pharmaceutical suppositories

• Vaginal pessaries

• Vaginal ovules

• Pharmaceutical creams

• Pharmaceutical ointments

Products can be manufactured according to the required composition, strength, specifications, packaging configuration and applicable Indonesian regulatory requirements.

Pharmaceutical Regulatory Authority in Indonesia

The Food and Drug Authority of Indonesia (BPOM) is responsible for the regulation of medicines and pharmaceutical products in Indonesia.

BPOM's Directorate of Drug Registration operates the official drug registration portal and provides registration information and consultation services for pharmaceutical stakeholders.

Pharmaceutical Registration in Indonesia

Medicines intended for commercial distribution in Indonesia are subject to the applicable BPOM registration and authorization requirements.

Depending on the product and registration pathway, technical documentation may include:

• Product registration application

• Manufacturer information

• Manufacturing licence

• GMP documentation

• Qualitative and quantitative composition

• Manufacturing process

• Finished-product specifications

• Analytical methods

• Certificate of Analysis

• Stability data

• Packaging specifications

• Labelling and package insert

• CPP, where applicable

• FSC, where applicable

• Product samples, where required

The final requirements depend on the product, dosage form, applicant and applicable BPOM pathway.

Pharmaceutical Import Requirements

Imported pharmaceutical products must comply with Indonesian pharmaceutical regulations and applicable BPOM procedures.

Depending on the product and shipment, documentation may include:

• Commercial invoice

• Packing list

• Certificate of Origin

• Bill of Lading or Air Waybill

• Certificate of Analysis

• Manufacturing licence

• GMP certificate

• Product registration documentation

• CPP or other regulatory certificates

• Packaging and labelling information

The Indonesian importer or marketing authorization applicant should confirm the current requirements before commercial shipment.

Suppositories for Indonesia

Global Entra Pharma manufactures pharmaceutical suppositories for selected therapeutic applications. Different strengths, formulations and packaging configurations can be produced according to the agreed product specification.

Pessaries for Indonesia

Vaginal pessaries provide a specialized dosage form for women's healthcare. Selected formulations can be manufactured with suitable active ingredients, strengths, formulation bases and packaging configurations.

Vaginal Ovules for Indonesia

Vaginal ovules provide flexibility for women's healthcare formulations. Manufacturing can accommodate selected active ingredients, suitable bases, strengths and packaging formats according to the agreed specification.

Pharmaceutical Creams for Indonesia

Pharmaceutical creams are used across dermatological, anti-infective and other topical therapeutic categories. Selected formulations can be manufactured according to the required strength, formulation and packaging specifications.

Pharmaceutical Ointments for Indonesia

Pharmaceutical ointments provide a semisolid dosage form for various topical applications. Manufacturing can be planned according to formulation, strength, packaging and quality specifications.

Quality and Regulatory Documentation

A suitable technical documentation package supports pharmaceutical registration and commercial supply. Depending on the product, it may include:

• Manufacturing licence

• GMP certificate

• Certificate of Analysis

• Product specifications

• Stability documentation

• Batch manufacturing documentation

• Packaging specifications

• CPP

• FSC

• Regulatory dossier

Documentation should be prepared according to the current requirements applicable to the specific Indonesian product registration pathway.

Private Label Pharmaceutical Manufacturing

Global Entra Pharma provides private-label manufacturing for selected pharmaceutical formulations. Buyers can specify composition, strength, packaging configuration, artwork and other technical requirements.

Private-label manufacturing enables pharmaceutical companies and distributors to develop products under their own approved brands while utilizing an Indian pharmaceutical manufacturing facility.

Contract Pharmaceutical Manufacturing from India

Global Entra Pharma supports contract manufacturing for selected finished pharmaceutical formulations.

Products can be manufactured according to agreed technical specifications, quality requirements, packaging configurations and applicable regulatory documentation.

For Indonesia, the responsibilities of the manufacturer, product applicant, importer and other regulated parties should be established before commercial supply.

Pharmaceutical Export Process to Indonesia

A typical export process can include:

1. Product selection

2. Strength and quantity confirmation

3. Commercial quotation

4. Technical and regulatory review

5. Registration requirement assessment

6. Dossier preparation

7. Packaging and artwork approval

8. Manufacturing

9. Quality control and batch release

10. Export documentation

11. Shipment to Indonesia

The actual process depends on the product, registration status, importer and applicable BPOM requirements.

Why Choose an Indian Pharmaceutical Manufacturer?

India is one of the world's major pharmaceutical manufacturing and export centres. Its pharmaceutical trade with Indonesia is well established, with India supplying approximately US$128.90 million of pharmaceutical products to Indonesia in 2025.

For Indonesian pharmaceutical buyers, manufacturing from India can provide access to specialized dosage forms, private-label production, customized packaging and structured pharmaceutical documentation.

Five Specialized Pharmaceutical Dosage Forms

Global Entra Pharma's specialized manufacturing portfolio includes:

• Suppositories

• Pessaries

• Vaginal ovules

• Pharmaceutical creams

• Pharmaceutical ointments

These dosage forms support applications across women's healthcare, dermatology, anti-infective therapy and other pharmaceutical categories.

Frequently Asked Questions

Can pharmaceutical products be exported from India to Indonesia?

Yes. India supplied approximately US$128.90 million of pharmaceutical products to Indonesia in 2025.

Who regulates medicines in Indonesia?

The Food and Drug Authority of Indonesia (BPOM) is responsible for pharmaceutical product regulation and drug registration.

Is pharmaceutical registration required in Indonesia?

Pharmaceutical products intended for commercial distribution are subject to the applicable BPOM registration and authorization requirements.

Does BPOM have an official drug registration system?

Yes. BPOM's Directorate of Drug Registration operates an official drug registration portal providing registration information and consultation services.

Can Global Entra Pharma manufacture private-label medicines for Indonesia?

Yes. Selected pharmaceutical formulations can be manufactured under private-label arrangements according to agreed specifications and applicable Indonesian requirements.

What documents may be required for registration?

Depending on the product, documentation may include manufacturing and GMP certificates, composition, specifications, analytical information, stability data, CoA, CPP, FSC, packaging information and product samples.

Pharmaceutical Export from India to Indonesia

Global Entra Pharma manufactures specialized pharmaceutical formulations for pharmaceutical buyers across Asian, African, Middle Eastern and other international markets. Its manufacturing portfolio includes suppositories, pessaries, vaginal ovules, pharmaceutical creams and ointments.

For pharmaceutical export to Indonesia, product registration, importer requirements, import procedures, labelling and technical documentation should be verified according to the current BPOM requirements applicable to the specific product.